HCPCS code J9311 — Inj rituximab, hyaluronidase.
Status: Active.
Effective Jan 1, 2019.
Source: CMS HCPCS Level II.
J9311
ActiveInj rituximab, hyaluronidase
Injection, rituximab 10 mg and hyaluronidase
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2019
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9467
Drug class:
Anti-CD20 Monoclonal Antibodies
MUE — Medically Unlikely Edits
Maximum units of J9311 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 160 |
| Practitioner Services | 160 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 50242-0108-01 | Rituxan Hycela |
| 50242-0109-01 | Rituxan Hycela |